These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2416202)

  • 1. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
    Rothbard JB; Schoolnik GK
    Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
    [No Abstract]   [Full Text] [Related]  

  • 2. Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili.
    Stephens DS; Whitney AM; Rothbard J; Schoolnik GK
    J Exp Med; 1985 Jun; 161(6):1539-53. PubMed ID: 2409203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonococcal pilus: genetics and structure.
    So M; Billyard E; Deal C; Getzoff E; Hagblom P; Meyer TF; Segal E; Tainer J
    Curr Top Microbiol Immunol; 1985; 118():13-28. PubMed ID: 2414068
    [No Abstract]   [Full Text] [Related]  

  • 4. Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin.
    Johnson SC; Chung RC; Deal CD; Boslego JW; Sadoff JC; Wood SW; Brinton CC; Tramont EC
    J Infect Dis; 1991 Jan; 163(1):128-34. PubMed ID: 1701817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
    Sparling PF; Cannon JG; So M
    J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple gonococcal pilin antigenic variants are produced during experimental human infections.
    Seifert HS; Wright CJ; Jerse AE; Cohen MS; Cannon JG
    J Clin Invest; 1994 Jun; 93(6):2744-9. PubMed ID: 7911129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sixth C. L. Oakley lecture. Molecular studies on the pathogenesis of gonorrhoea.
    Heckels JE
    J Med Microbiol; 1984 Dec; 18(3):293-307. PubMed ID: 6209398
    [No Abstract]   [Full Text] [Related]  

  • 8. Understanding the structure and antigenicity of gonococcal pili.
    Getzoff ED; Parge HE; McRee DE; Tainer JA
    Rev Infect Dis; 1988; 10 Suppl 2():S296-9. PubMed ID: 2903537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved DNA sequence is required for efficient gonococcal pilin antigenic variation.
    Wainwright LA; Pritchard KH; Seifert HS
    Mol Microbiol; 1994 Jul; 13(1):75-87. PubMed ID: 7984095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae.
    Hagblom P; Segal E; Billyard E; So M
    Nature; 1985 May 9-15; 315(6015):156-8. PubMed ID: 2859529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic variation in gonococcal pili explained.
    Saunders JR
    Nature; 1985 May 9-15; 315(6015):100-1. PubMed ID: 2859528
    [No Abstract]   [Full Text] [Related]  

  • 13. Probing the surface of Neisseria gonorrhoeae: immunoelectron microscopic studies to localize cyanogen bromide fragment 2 in gonococcal pili.
    Robinson EN; Clemens CM; Schoolnik GK; McGee ZA
    Mol Microbiol; 1989 Jan; 3(1):57-64. PubMed ID: 2469938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion.
    Rothbard JB; Fernandez R; Wang L; Teng NN; Schoolnik GK
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):915-9. PubMed ID: 3919385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and antigenicity of the Neisseria gonorrhoeae pilus mapped with antibodies.
    Forest KT; Bernstein SL; Getzoff ED; So M; Tribbick G; Geysen HM; Deal CD; Tainer JA
    Infect Immun; 1996 Feb; 64(2):644-52. PubMed ID: 8550220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questions about gonococcal pilus phase- and antigenic variation.
    Seifert HS
    Mol Microbiol; 1996 Aug; 21(3):433-40. PubMed ID: 8866467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis.
    Virji M; Heckels JE
    J Gen Microbiol; 1989 Jul; 135(7):1895-9. PubMed ID: 2482335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations.
    Wetzler LM; Blake MS; Gotschlich EC
    J Exp Med; 1988 Nov; 168(5):1883-97. PubMed ID: 3141555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common epitopes of pilin of Neisseria meningitidis.
    Stephens DS; Whitney AM; Schoolnik GK; Zollinger WD
    J Infect Dis; 1988 Aug; 158(2):332-42. PubMed ID: 2457056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae.
    Lammel CJ; Sweet RL; Rice PA; Knapp JS; Schoolnik GK; Heilbron DC; Brooks GF
    J Infect Dis; 1985 Nov; 152(5):990-1001. PubMed ID: 2413148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.